normal range, and TSH concentrations are commonly within the normal range. Some patients with iodothyronine levels in the lower part of the normal range and with normal TSH concentrations may also have TSH-D due to dysfunction of TSH secretion. Such values may be interpreted as normal. These patients may remain clinically puzzling and thus are often not treated with thyroid replacement medication. Failure to recognize and treat TSH-D can result in poor growth and less than optimal state of health (13, 14) .
In normal infants, children, and adults, the circadian pattern of serum TSH concentration is characterized by declining values throughout the morning, nadir values in the afternoon, and an approximate doubling or surge in the evening with peak values in the early morning (15) (16) (17) (18) (19) (20) . In normal children and adults, nocturnal TSH concentrations typically rise 50-300% above the nadir value after early evening. In the TSH surge test, the circadian pattern of TSH secretion is sampled as a probe of the intactness of the hypothalamic-pituitary-thyroid axis (1 1, 16 ). The author has previously shown that in TSH-D the nocturnal TSH surge is blunted or absent, the nocturnal TSH surge is a sensitive (and specific) test for identification of TSH-D, whereas use of a TRH test is less sensitive than the TSH surge in children with multiple hormone deficiencies (1 1).
It was hypothesized that some slowly growing children with no other identifiable cause of their short stature might have isolated TSH-D. This report describes the incidence of isolated TSH-D identified using the nocturnal TSH surge in children otherwise diagnosed with ISS.
METHODS
The study was approved by the Human Research Committee at each of the following institutions: the National Institute of Child Health and Human Development of the National Institutes of Health (National Institutes of Health), the University of New Mexico (UNM), and the University of Tennessee, Memphis (UT). The population from which children were identified for this study included all sequential admissions by the author between 1986 and 1994 for evaluation of height two or more SD below the mean for age. Two-thirds of the children were male (n = 235, ages 1-17 y, 74 girls), consistent with frequently found referral patterns in the United States. Causes for exclusion included intercurrent acute or chronic illness, glucocorticoid requirement, depression or other psychiatric diagnosis, rapid growth, history of radiation therapy for oncologic processes, Turner syndrome, and skeletal dysplasias. The subjects were admitted to the National Institutes of Health Clinical Center, the UNM General Clinical Research Center, or the UT General Clinical Research Center.
Procedures. Signed informed consent was obtained from one parent and assent from each child. Morning height was measured by stadiometer. Radiograph of the left hand and wrist was interpreted for bone maturation according to the standards of Greulich and Pyle. A standard pediatric diet was provided, and sleep period was monitored by nursing observation.
An i.v. catheter for blood drawing access was maintained with 0.5-1.0 mL of heparin (100 U/mL) after each blood draw. Blood samples were drawn hourly from 1400 until 1800 h (time of TSH nadir) and from 2200 until 0400 h (time of TSH peak) for TSH assay (Fig. 1) . Simultaneous study of overnight GH concentrations (2000 until 0800 h, every 20 min of Sampling for GH assay) was performed in 162 of the children. Subsequently, standard GH stimulation tests (arginine, insulin, and L-dopa; or arginine and L-dopa) were performed in all children after pretreatment with estradiol in peripubertal children (older than age 8 but not yet stage 3 of puberty) (8, 10). TRH test (protirelin 7 p g k g i.v., maximum dose, 500 pg) was performed in 145 of the children (1 1).
To evaluate the clinical utility of the TSH surge in predicting growth response to therapy with thyroid hormone, a pilot study was performed. Ten of the ISS children with FT, in the lowest third of the normal range, 22 of the ISS children with FT, in the upper two-thirds of the normal range, and 6 of the children with FT, in the lowest third of the normal range and blunted TSH surge participated in a treatment trial during 18 mo, with evaluation of basal growth velocity during the first and third 6-mo intervals. During the second 6-mo interval, patients took levothyroxine (Synthroid) daily in doses that achieved an increase in serum FT, concentration of 6.0 f 1.0 pmol/L (mean f SD), resulting in FT, concentrations during treatment that remained in the normal range. The Synthroid dose required t t t t t 1 in these children to achieve treatment concentrations was 2.8 ? 0.4 pg/kg/d. Growth velocity data were used in analysis only from those children who remained prepubertal throughout the 18-mo period. Assays. The specific methodology available for TSH assay was different at each study location; however, each assay was ultrasensitive and involved antibodies to three sites on the TSH molecule (Table 1) . Because each patient's peak TSH value was analyzed relative to his or her own nadir TSH value, minor differences between assays were compensated for in interpre- 
tation of results. FT, assay at each study site involved direct RIA of FT, rather than calculated or derived values (Table 1) . Serum GH was assayed by polyclonal RIA: National Institutes of Health and UNM samples at Hazleton Washington (Vienna, VA), and UT samples at Endocrine Sciences (Calabasas Hills, CA). Samples for all spontaneous GH studies were assayed at Hazleton Washington.
Analysis. The short children were divided into four groups (Table 2) : ISS included children with entirely normal GH and thyroid studies; the GHD group (peak stimulated GH of 7 p g L or less); the high TSH group included children with mild primary hypothyroidism (TSH 5-15 mU/L); and the TSH-D group (blunted TSH surge).
Peak GH referred to the highest GH value observed during any stimulation test. Mean night GH referred to the mean of all 37 GH values obtained during the overnight GH study (21).
The nocturnal TSH surge was calculated by subtracting the TSH nadir (three sequential values in the afternoon yielding the lowest mean TSH) from the TSH peak (three sequential values at night yielding the highest mean TSH) and dividing the difference by the TSH nadir, expressing the result as percent rise over nadir (Fig. I ). Results were compared with 95% confidence limits of values observed in 96 normal children previously reported by the author (16). TSH surge results between 50 and 300% were considered normal.
The TRH test was evaluated according to magnitude of TSH peak (amount of rise above baseline TSH level), time of TSH peak (minutes after TRH was given), and response curve decline (percent of magnitude of TSH peak remaining at 60 min after time of TSH peak). Results were compared with 95% confidence limits of values observed by the author in 76 normal children (1 1).
Analysis of variance with the Bonferroni adjustment for multiple comparisons was used to evaluate possible statistical differences among groups. Repeated measures analysis of variance was used in evaluating changes in growth velocity in the treatment trial.
RESULTS
During the 9-y period of study, the author diagnosed in this population 39 children with GHD (GH peak 5 7 ng/dL) and 15 children with mild primary hypothyroidism (TSH at 0900 h, 5-15 mUL) not previously apparent as an outpatient. The remaining 18 1 children met generally accepted criteria for the diagnosis of ISS.
However, 30 of the 181 children (four girls, 13%) were found to have a low TSH surge, whereas 15 1 children (5 1 girls, 33%) had a normal TSH surge (Table 3 ). All 30 children with a blunted TSH surge had FT, in the lower third of the normal range. Thus, use of a FT, cutoff value dividing the lower third from the rest of the normal range (to identify a subgroup of short children in whom the TSH surge should be performed) would have identified 100% of these children with isolated TSH-D (Fig. 2) .
The children with TSH-D were 13% of the total group of referred short children but were 32% of the 92 children with apparent ISS who had FT, in the lowest third of the normal range. By comparison, GHD was concurrently diagnosed in 16% of the total group of referred short children. Of 39 children diagnosed with GHD, 7 (18%) were identified as also having TSH-D, a commonly associated deficiency. The incidence of children with TSH-D was similar at each of the study locations, suggesting no regional differences in distribution of diagnoses. Bone age was significantly delayed in GHD (2.1 y) and 1.9 y delayed in TSH-D, whereas delay was less in the other groups (1.2 y in high TSH, 1.5 y in ISS) ( Table 2) .
TSH response to TRH did not differ significantly among groups, with the exception of high TSH in which an exaggerated magnitude of TSH peak response to TRH was seen (Table  3) . In TSH-D, only 2 of the 22 patients who had the TRH test performed had delayed time of TSH peak and also delayed response curve decline. No patient had a subnormal magnitude of TSH peak (Fig. 3) . Thus, TRH testing would have failed to confirm the diagnosis in 91% of the TSH-D patients.
The peak stimulated GH and mean night GH results in GHD were significantly lower than in ISS (both p < 0.01). However, GH results in TSH-D or high TSH were not different from GH results in ISS (Table 2 ). Both hypothyroid groups had mean FT, values which were significantly lower than mean FT, in the ISS group, but which remained within the low part of the normal range. These observations suggest that mild hypothyroidism of the degree observed in these two groups does not in itself significantly alter the clinician's ability to accurately and simultaneously assess GH status (Fig. 4) . Nocturnal TSH Surge (%) Levothyroxine treatment during 6 mo resulted in no significant change in growth velocity in either group of ISS children. However, a significant increase in growth velocity was observed in TSH-D during levothyroxine therapy compared with both baseline growth velocity and follow-up growth velocity (p = 0.03 and 0.01, respectively) ( 
DISCUSSION
In this study of children referred for evaluation of height shorter than 2 SD below the mean for age, a significant incidence of isolated TSH-D was found (13%). This was four-fifths of the incidence of classic GHD identified by the author during the same time period. This surprisingly high incidence was a product of using a new diagnostic test, the TSH surge, which has been shown to have increased sensitivity compared with the TRH test in the diagnosis of TSH-D (1 1). It was possible to use FT, as a screening test to identify those children most at risk for this disorder. Isolated TSH-D was Normal ISS HighTSH TSH-D is consistent with the finding by the author and others that, although i.v. TRH has been the most frequent test used to confirm TSH-D, 50-85% of patients with TSH-D have demonstrated a TSH response to TRH which was normal in both amplitude and timing (11, 13, 22). Thus, there is a significant overlap between the normal pattern of TSH response to TRH and that seen in hypothalamic disorders of TSH release. In a patient with TSH-D, the TSH response to TRH may be abnormal and confirm the disorder or may resemble the response to TRH seen in primary hypothyroidism, but is even more likely to be normal and miss the diagnosis (1 1, 13, 22, 54) .
Children with TSH-D given levothyroxine therapy for 6 mo had a significant increase in growth velocity, whereas ISS children given similar doses for 6 mo did not significantly increase their growth velocity. Growth velocity in hypothyroidism has been described to be sensitive to small changes in thyroid hormone concentration in the absence of other symptoms of hypothyroidism (23). The results of the pilot treatment study suggest that short children with blunted TSH surge and slow growth velocity will probably benefit from thyroid hormone therapy.
The mild degree of hypothyroidism observed in these children with either TSH-D or mild primary hypothyroidism did not result in "low" GH responses to stimulation tests or in low overnight GH measures. This suggests that GH evaluation can be accurately performed simultaneously with TSH evaluation in children with FT, in the lower third of the normal range.
At a practical level it is difficult to cause a false positive blunting of the TSH surge. Artifactual blunting of the TSH surge can occur after fasting (24) (Rose SR, unpublished observation); however, this was not the cause in the current study where the testing conditions included a standard ageappropriate diet with monitored intake. Delayed time of falling asleep or altered quality of sleep in the hospital will not cause a blunted TSH surge. In fact, poor sleep or delayed sleep latency result in augmentation of the rise in TSH at night (25). For these reasons, blunting of the TSH surge is rare in the test setting and commonly correlates with true clinical abnormality rather than artifact.
Transient or permanent alteration of the TSH surge has been described in hypercortisolemia (26), critical illness (27-30), postoperative recovery (31), hyperglycemia (32), chronic renal failure (33, 34) , depression (35-38), and aging (39) . None of these was present in the children studied in this project. Mild primary hypothyroidism does not significantly alter the TSH surge (1 1, 40) .
TSH-D can be observed in association with any etiology of hypothalamic-pituitary disorder (11, 13, 17, 41) . It is present as a second deficiency in approximately 10-25% of children with idiopathic GHD and in 25-50% of children with organic causes of hypopituitarism (11) (12) (13) (14) . However, isolated TSH-D is thought to be rare and reportable. The case reports in the literature tend to be of patients with low serum TSH and no response to TRH. Congenital hypothyroidism with low TSH concentrations due to abnormality of the P subunit of the TSH molecule has been described in several Japanese and Greek families (42) (43) (44) (45) . A dozen other individuals with isolated TSH deficiency (low TSH levels and failure to respond to TRH) have been reported (46) (47) (48) (49) (50) (51) . There are only two case reports of isolated TRH deficiency, one after meningitis, and one proposed to be secondary to hypophysitis (52, 53) . In contrast, the abnormalities in circadian pattern of TSH concentrations reported in the current study are less easily recognized without specialized testing such as the TSH surge. However, testing of the TSH surge has only recently been used in diagnosis. It is probable that, to date, testing methods have been inadequately sensitive to identify this condition without the presence of strong clinical suspicion.
The mechanism by which isolated TSH-D occurs could include limitation of hypothalamic TRH secretion, alteration of neuroendocrine signals mediating the circadian clock, or alteration of the structure of the TSH molecule (13, 14, 51) . The abnormality could be congenital or could result from subtle birth injury, infection, mild head injury, or other acquired cause.
Subtle or subclinical primary hypothyroidism ("lownormal" thyroid function tests with an elevated TSH) is a commonly recognized clinical condition. In the setting of TSH-D (low-normal thyroid function tests with TSH in the normal range), the diagnosis is usually not made because the patient is unable to elevate TSH concentrations. Thus, TSH-D is a subtle abnormality which is often missed in clinical and laboratory diagnosis of the etiology of short stature. Loss of the nocturnal serum TSH rise represents impairment of TSH secretion which is not revealed by baseline morning measures of TSH or evaluation of the TSH response to TRH. The absence of rise in TSH secretion at night (approximately 30% of the total daily TSH secretion) is associated with a proportionate decrease both in stimulation of the thyroid gland and in total iodothyronine production. This decrease, although subtle, may be enough to account for slowed growth in some children otherwise thought to have ISS. Subtle hypothyroidism can also result in delay of maturation, perhaps contributing in an occa- 15 
